Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study

Abstract The response to icotinib in advanced non‐small cell lung cancers (NSCLC) with EGFR uncommon mutation (EGFRum) is unclear. Here we reported the efficacy and potential resistance mechanism of icotinib in Chinese EGFRum NSCLC patients. Between July 2013 and November 2016, 3117 NSCLC patients w...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lei Lei, Wen‐xian Wang, You‐cai Zhu, Jin‐luan Li, Yong Fang, Hong Wang, Wu Zhuang, Yin‐bin Zhang, Li‐ping Wang, Mei‐yu Fang, Chun‐wei Xu, Xiao‐jia Wang, Tang‐feng Lv, Yong Song
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2020-01-01
coleção:	Cancer Medicine
Assuntos:	ctDNA EGFR icotinib NGS NSCLC
Acesso em linha:	https://doi.org/10.1002/cam4.2652
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!